Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-08-13 | New | $9,475,000 | Unknown | Equity Only | SEC link | |
| 2025-07-09 | New | $1,425,000 | $1,425,000 | Equity Only | 06b | SEC link |
| 2022-05-20 | New | $96,972 | $96,972 | Equity Only | 06b | SEC link |
| 2020-05-18 | New | $55,000 | $55,000 | Equity Only | 06b | SEC link |
| 2019-06-04 | New | $857,430 | $857,430 | Equity Only | 06b | SEC link |
| 2019-06-04 | New | $4,192,990 | $4,192,990 | Equity Only | 06b | SEC link |
| 2018-09-14 | New | $525,824 | $525,824 | Equity Only | 06b | SEC link |
| 2018-04-06 | New | $850,786 | $850,786 | Equity Only | 06b | SEC link |
| 2017-06-05 | New | Yet to Sell | $0 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| John W. Beck | Director |
| Douglas Blayney | Director |
| R. Martin Emanuele | Director |
| Georgia Erbez | Director |
| Tamara A. Favorito | Director |
| Gregory D. Gorgas | Director, Executive |
| Steven Kelly | Director |
| Connie Matsui | Director |
| Peter O'brien | Director, Executive |
| Gregory R. Reyes | Director |
| Tamara A. Seymour | Director |